AbCellera Biologics Inc. (ABCL) vs Option Care Health, Inc. (OPCH)
A side-by-side comparison of AbCellera Biologics Inc. and Option Care Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABCL
AbCellera Biologics Inc.
$13.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OPCH
Option Care Health, Inc.
$31.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABCL vs OPCH
growth of $100 · dividends reinvested · last 6yABCL -76.6% (-21.5%/yr)OPCH +46.2% (+6.5%/yr)OPCH compounded faster over this window
Log scale — wide-divergence pair
ABCL OPCH
ABCL vs OPCH: by the numbers
- •OPCH is the larger company ($4.64B vs $4.02B market cap).
- •OPCH is profitable (3.68% net margin) while ABCL runs a net loss (-248.83%).
- •OPCH grew revenue faster over the past five years (12.17% vs -31.78% CAGR).
Metrics side by side
Valuation
| Metric | ABCL | OPCH |
|---|---|---|
| P/E ratio | N/A | 23.31 |
| Forward P/E | N/A | 16.49 |
| P/S ratio | 60.68 | 0.82 |
| P/B ratio | 4.48 | 3.69 |
| EV / EBITDA | N/A | 13.96 |
Profitability
| Metric | ABCL | OPCH |
|---|---|---|
| Gross margin | 61.64% | 18.17% |
| Operating margin | -288.98% | 5.94% |
| Net margin | -248.83% | 3.68% |
| ROE | -18.38% | 16.63% |
| ROIC | -17.95% | 9.68% |
Growth (annualized)
| Metric | ABCL | OPCH |
|---|---|---|
| Revenue CAGR (5Y) | -31.78% | 12.17% |
| Total return CAGR (5Y) | -3.57% | -1.37% |
Frequently asked
- Which has grown faster, ABCL or OPCH?
- Over the past five years, OPCH grew revenue faster — ABCL at a -31.78% CAGR versus OPCH at 12.17%.
- Is ABCL or OPCH more profitable?
- OPCH runs the higher net margin — ABCL at -248.83% versus OPCH at 3.68%.
- How have ABCL and OPCH total returns compared?
- Over the past 5 years, ABCL delivered -3.57% and OPCH delivered -1.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.